19 assets in Primary Effusion Lymphoma

Therapeutic assets addressing Primary Effusion Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Vincristine Sulfate Primary Effusion Lymphoma	National Cancer Institute (NCI)	P2	BBB (74)
Etoposide Primary Effusion Lymphoma	National Cancer Institute (NCI)	P2	BBB (72)
Adriamycin Primary Effusion Lymphoma	National Cancer Institute (NCI)	P2	BB (70)
Cyclophosphamide Primary Effusion Lymphoma	National Cancer Institute (NCI)	P2	BB (70)
Prednisone Primary Effusion Lymphoma	National Cancer Institute (NCI)	P2	BB (70)
Rituximab Primary Effusion Lymphoma	National Cancer Institute (NCI)	P2	BB (70)
(+)-Vincristine Primary Effusion Lymphoma	National Cancer Institute (NCI)	P2	BB (65)
Nivestim Primary Effusion Lymphoma	City of Hope Medical Center	P2	B (63)
Daratumumab Primary Effusion Lymphoma	National Cancer Institute (NCI)	P2	CCC (53)
Nivolumab Primary Effusion Lymphoma	National Cancer Institute (NCI)	P2	CCC (53)
Lenalidomide Primary Effusion Lymphoma	National Cancer Institute (NCI)	P1/2	CC (47)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer Primary Effusion Lymphoma	National Cancer Institute (NCI)	P2	CC (44)
Busulfanum Primary Effusion Lymphoma	City of Hope Medical Center	P1	CC (43)
Fludarabine Primary Effusion Lymphoma	City of Hope Medical Center	P1	CC (43)
Ibrutinib Primary Effusion Lymphoma	National Cancer Institute (NCI)	P1	CC (43)
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine) Primary Effusion Lymphoma	National Cancer Institute (NCI)	P1	CC (43)
Lentivirus Vector Rhiv7-Shi-Tar-Ccr5Rz-Transduced Hematopoietic Stem/Progenitor Cells Primary Effusion Lymphoma	City of Hope Medical Center	P1	CC (43)
Pegfilgrastim Primary Effusion Lymphoma	National Cancer Institute (NCI)	P1	CC (43)
Sgr-1505 Primary Effusion Lymphoma	Schrödinger, Inc.	P1	CC (43)